DU

Dr.Krishna Upadhye

Also known as: Upadhye Krishna

Krescent Medical Research Pvt Ltd, Sunrise University, NMIMS School of Pharmacy and Technology Management

ORCID iD 0009-0005-9805-7914
Follow

About

Dr. Krishna S. Upadhye is a clinical pharmacologist and clinical research professional with over 14 years of extensive experience across the pharmaceutical industry, hospitals, and academia. He currently serves as the director of clinical operations and strategy and founder of Krescent Medical Research Pvt. Ltd., a contract research organization (CRO) located in Pune, India.

He leads end-to-end clinical trial execution across Phase I–IV studies, ensuring adherence to ICH-GCP, CDSCO, USFDA, and EMA guidelines. His role includes overseeing clinical management functions, optimizing patient recruitment, and managing sponsor communications. Dr. Upadhye also drives business development, building strategic partnerships with global pharmaceutical, biopharmaceutical, and CRO organizations and actively working on expanding operations into the US market.

Dr. Upadhye earned his PhD in clinical pharmacology from Sunrise University, Alwar, with a research focus on the study of anemia in CKD and drug safety. He has been actively involved in the design and execution of Phase I–IV clinical trials and investigator-initiated studies, specializing in therapeutic areas such as nephrology, oncology, infectious diseases, and immunology. His scientific strengths include protocol development, PK/PD assessments, pharmacovigilance, and regulatory documentation.

Throughout his career, he has successfully collaborated with global pharmaceutical and biopharmaceutical companies, international CROs, and multinational trial sponsors, ensuring compliance with international GCP standards and operational excellence in multi-site studies.

Dr. Upadhye has written and published many review and systematic articles on new topics like precision medicine, genomics, serious side effects in clinical trials, multi-omics biomarker discovery, diabetes, anemia in chronic kidney disease, and CRISPR-Cas9 applications. He is also pursuing postdoctoral research opportunities in nephrology and translational pharmacology while mentoring young researchers and PhD aspirants.

His long-term mission is to bridge science and strategy by delivering high-quality, patient-centered clinical research through innovation, collaboration, and integrity.

Employment

  • Krescent Medical Research Pvt Ltd Director
    2021 - Present

Education

  • Sunrise University PhD
    2020 - 2024
  • NMIMS School of Pharmacy and Technology Management Master
    2009 - 2011

Projects & Funding

Projects & funding information is unavailable.

Publications (18)